1. Home
  2. CSTL vs SXC Comparison

CSTL vs SXC Comparison

Compare CSTL & SXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$39.54

Market Cap

661.7M

Sector

Health Care

ML Signal

HOLD

Logo SunCoke Energy Inc.

SXC

SunCoke Energy Inc.

HOLD

Current Price

$6.47

Market Cap

549.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTL
SXC
Founded
2007
1960
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Steel/Iron Ore
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
661.7M
549.5M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
CSTL
SXC
Price
$39.54
$6.47
Analyst Decision
Strong Buy
Hold
Analyst Count
6
1
Target Price
$38.67
$10.00
AVG Volume (30 Days)
588.2K
1.6M
Earning Date
11-03-2025
11-04-2025
Dividend Yield
N/A
7.36%
EPS Growth
N/A
N/A
EPS
N/A
0.75
Revenue
$343,530,000.00
$1,843,100,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$8.70
Revenue Growth
10.15
N/A
52 Week Low
$14.59
$6.24
52 Week High
$40.61
$12.71

Technical Indicators

Market Signals
Indicator
CSTL
SXC
Relative Strength Index (RSI) 80.57 36.65
Support Level $33.03 $6.24
Resistance Level $35.49 $6.60
Average True Range (ATR) 1.56 0.21
MACD 0.33 0.02
Stochastic Oscillator 85.93 30.43

Price Performance

Historical Comparison
CSTL
SXC

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

About SXC SunCoke Energy Inc.

SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is primarily used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through three segments: Domestic Coke, Brazil Coke, and Logistics. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.

Share on Social Networks: